Consortium advancing cancer care for people with HIV
Official title: Consortium for Advancing Management and Prevention of Cancer in People with HIV
Funded at Icahn School of Medicine at Mount Sinai · NIH-11535255 · Data updated 2026-11-12
A nationwide and international network tests new cancer treatments and prevention strategies specifically for people living with HIV.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | August 29, 2006 |
| Project end | August 31, 2030 |
| Funding year | 2026 |
| Award (this year) | $169,374 |
| NIH project number | 3UM1CA121947-20S7 |
| Project ID | NIH-11535255 on NIH RePORTER |
Who could benefit from this research
✓Could help
Individuals living with HIV who are affected by cancer or are at risk for AIDS-associated cancers.
✕Less likely to help
People without HIV-related cancer or those not eligible for a given trial may not directly benefit.
What this research studies
The AIDS Malignancy Consortium (AMC) runs clinical trials to find better ways to treat and prevent cancers that occur most often in people with HIV. Researchers collaborate across 39 trial sites to study from biology to patient care, sharing findings to improve guidelines globally. If you have HIV and cancer or are at risk, this program could influence future therapies and prevention options.
Why it matters
Potential benefit: If successful, this work could lead to better cancer treatment and prevention strategies for people living with HIV.
How similar studies have gone: Past AMC trials have shaped practice guidelines and shown substantial contributions to patient care in this field.
Where this research is happening
-
Icahn School of Medicine at Mount Sinai
New York, United States Active
Researchers
- Principal investigator: Sparano, Joseph a. — Icahn School of Medicine at Mount Sinai
- Study coordinator: Sparano, Joseph a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.